Assessing Amcor’s Valuation After Recent Mixed Share Price Performance

How Amcor’s Recent Performance Might Look to Investors

Amcor (AMCR) has been on investors’ radar after recent trading, with the share price near $41.16 and mixed short term returns, including gains over the past week and month but weaker past 3 months and 1 year performance.

See our latest analysis for Amcor.

At around $41.16, Amcor’s 7 day share price return of 3.08% contrasts with a 90 day share price return decline of 4.39% and a 1 year total shareholder return loss of 6.54%. This suggests recent momentum has picked up after a weaker stretch.

If you are weighing Amcor against other ideas in your portfolio, it can help to see what else the market is offering through a focused screener such as 18 top founder-led companies

With Amcor trading around $41.16, some value indicators and its recent mixed returns raise a key question for investors: Is the stock still trading below what it is worth, or is the market already pricing in future growth?

Most Popular Narrative: 723.2% Overvalued

According to the narrative by andy_c, the fair value estimate of $5.00 sits far below Amcor’s last close of $41.16, which creates a wide valuation gap that hinges on a detailed assessment of quality, leverage, and dividends.

Margin of Safety – Range: minus 70% to plus 35%; Buffett’s preferred: Above 25%; Status: ⚠️; Explanation: Relative to the three valuation methods, the stock looks overvalued versus DCF but undervalued versus P/B, producing a wide margin of safety range from negative 70% to positive 35%.

Read the complete narrative.

The valuation hinges on how resilient free cash flow really is, how much leverage the business can comfortably support, and what earnings power looks like post merger. Want to see how those moving parts shape this fair value call and the implied margin of safety range?

Result: Fair Value of $5.00 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, if merger integration improves cash flow or high leverage is reduced faster than expected, this very large valuation gap could appear less extreme.

Find out about the key risks to this Amcor narrative.

Another Way to Look at Amcor’s Value

While the user narrative sees Amcor as very overvalued at $41.16 versus a $5.00 fair value, Simply Wall St’s DCF model points the other way, with a future cash flow value of $71.84 and the shares trading at a 42.7% discount. Which story feels more realistic to you?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Amcor for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 58 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The mixed picture on price, fair value, and sentiment makes this a stock where you really need to look under the hood yourself. Move quickly to review both sides of the story and weigh up the 3 key rewards and 5 important warning signs

Looking for more investment ideas?

If Amcor has sharpened your thinking, do not stop here. Broaden your watchlist and compare alternatives so you are not relying on a single story.

• Target potential value opportunities by scanning 58 high quality undervalued stocks that combine quality fundamentals with pricing that may still leave room on the table.
• Strengthen your focus on resilience by checking 72 resilient stocks with low risk scores that score well on stability and may cushion your portfolio during tougher periods.
• Stay a step ahead by reviewing the screener containing 23 high quality undiscovered gems before they sit on everyone else’s radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com